Matches in SemOpenAlex for { <https://semopenalex.org/work/W2751993893> ?p ?o ?g. }
- W2751993893 endingPage "S24" @default.
- W2751993893 startingPage "S15" @default.
- W2751993893 abstract "Asthma is frequently undertreated, resulting in a relatively high prevalence of patients with uncontrolled disease, characterized by the presence of symptoms and risk of adverse outcomes. Patients with uncontrolled asthma have a higher risk of morbidity and mortality, underscoring the importance of identifying uncontrolled disease and modifying management plans to improve control. Several assessment tools exist to evaluate control with various cutoff points and measures, but these tools do not reliably correlate with physiological measures and should be considered a supplement to physiological tests. When attempting to improve control in patients, nonpharmacological interventions should always be attempted before changing or adding pharmacotherapies. Among patients with severe, uncontrolled asthma, individualized treatment based on asthma phenotype and eosinophil presence should be considered. The efficacy of the anti-IgE antibody omalizumab has been well established for patients with allergic asthma, and novel biologic agents targeting IL-5, IL-13, IL-4, and other allergic pathways have been investigated for patients with allergic or eosinophilic asthma. Fevipiprant (a CRTH2 [chemokine receptor homologous molecule expressed on Th2 cells] antagonist) and imatinib (a tyrosine kinase inhibition) are examples of nonbiologic therapies that may be useful for patients with severe, uncontrolled asthma. Incorporation of new and emerging treatment into therapeutic strategies for patients with severe asthma may improve outcomes for this patient population." @default.
- W2751993893 created "2017-09-15" @default.
- W2751993893 creator A5044980958 @default.
- W2751993893 creator A5047213494 @default.
- W2751993893 date "2017-09-01" @default.
- W2751993893 modified "2023-10-01" @default.
- W2751993893 title "New and Anticipated Therapies for Severe Asthma" @default.
- W2751993893 cites W1506450640 @default.
- W2751993893 cites W1835779809 @default.
- W2751993893 cites W1869441945 @default.
- W2751993893 cites W1886211687 @default.
- W2751993893 cites W1935737468 @default.
- W2751993893 cites W1949221250 @default.
- W2751993893 cites W1965428022 @default.
- W2751993893 cites W1965484089 @default.
- W2751993893 cites W1967215794 @default.
- W2751993893 cites W1968699024 @default.
- W2751993893 cites W1974074892 @default.
- W2751993893 cites W1985951914 @default.
- W2751993893 cites W1990630620 @default.
- W2751993893 cites W1991886932 @default.
- W2751993893 cites W1993076029 @default.
- W2751993893 cites W1995137037 @default.
- W2751993893 cites W2018829247 @default.
- W2751993893 cites W2029587541 @default.
- W2751993893 cites W2032240032 @default.
- W2751993893 cites W2055172715 @default.
- W2751993893 cites W2055589748 @default.
- W2751993893 cites W2060912065 @default.
- W2751993893 cites W2061775758 @default.
- W2751993893 cites W2063780624 @default.
- W2751993893 cites W2068870295 @default.
- W2751993893 cites W2075699130 @default.
- W2751993893 cites W2084213720 @default.
- W2751993893 cites W2086332783 @default.
- W2751993893 cites W2089507426 @default.
- W2751993893 cites W2098745523 @default.
- W2751993893 cites W2105880697 @default.
- W2751993893 cites W2108919922 @default.
- W2751993893 cites W2110534370 @default.
- W2751993893 cites W2111033333 @default.
- W2751993893 cites W2111609315 @default.
- W2751993893 cites W2121739711 @default.
- W2751993893 cites W2122829970 @default.
- W2751993893 cites W2124892479 @default.
- W2751993893 cites W2131002322 @default.
- W2751993893 cites W2138355864 @default.
- W2751993893 cites W2145977358 @default.
- W2751993893 cites W2151041131 @default.
- W2751993893 cites W2151256680 @default.
- W2751993893 cites W2155144195 @default.
- W2751993893 cites W2161775889 @default.
- W2751993893 cites W2162590783 @default.
- W2751993893 cites W2196782018 @default.
- W2751993893 cites W2309688181 @default.
- W2751993893 cites W2335100178 @default.
- W2751993893 cites W2338443462 @default.
- W2751993893 cites W2339358422 @default.
- W2751993893 cites W2342693354 @default.
- W2751993893 cites W2431068257 @default.
- W2751993893 cites W2443702503 @default.
- W2751993893 cites W2470603608 @default.
- W2751993893 cites W2475880293 @default.
- W2751993893 cites W2501022427 @default.
- W2751993893 cites W2511120040 @default.
- W2751993893 cites W2515900781 @default.
- W2751993893 cites W2516474168 @default.
- W2751993893 cites W2519336471 @default.
- W2751993893 cites W2520952897 @default.
- W2751993893 cites W2521435480 @default.
- W2751993893 cites W2529467795 @default.
- W2751993893 cites W2553441977 @default.
- W2751993893 cites W2557690760 @default.
- W2751993893 cites W2592766983 @default.
- W2751993893 cites W2594220482 @default.
- W2751993893 cites W2594813104 @default.
- W2751993893 cites W2603275790 @default.
- W2751993893 cites W2615078498 @default.
- W2751993893 cites W2619633721 @default.
- W2751993893 cites W2956481022 @default.
- W2751993893 doi "https://doi.org/10.1016/j.jaip.2017.07.008" @default.
- W2751993893 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28888244" @default.
- W2751993893 hasPublicationYear "2017" @default.
- W2751993893 type Work @default.
- W2751993893 sameAs 2751993893 @default.
- W2751993893 citedByCount "23" @default.
- W2751993893 countsByYear W27519938932018 @default.
- W2751993893 countsByYear W27519938932019 @default.
- W2751993893 countsByYear W27519938932020 @default.
- W2751993893 countsByYear W27519938932021 @default.
- W2751993893 countsByYear W27519938932022 @default.
- W2751993893 crossrefType "journal-article" @default.
- W2751993893 hasAuthorship W2751993893A5044980958 @default.
- W2751993893 hasAuthorship W2751993893A5047213494 @default.
- W2751993893 hasConcept C126322002 @default.
- W2751993893 hasConcept C141105273 @default.
- W2751993893 hasConcept C159654299 @default.
- W2751993893 hasConcept C177713679 @default.